What Researchers Did
Researchers reported on a case of a 42-year-old woman with refractory pyoderma gangrenosum treated with hyperbaric oxygen therapy after conventional treatments failed.
What They Found
After a 42-year-old woman's pyoderma gangrenosum remained unresponsive to conventional treatments, including infliximab for 12 weeks and adalimumab, hyperbaric oxygen therapy was initiated. This salvage treatment led to a positive resolution of her refractory pyoderma gangrenosum.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
As a single case report, the findings of this study cannot be generalized to a broader patient population.